BANGKOK LAB AND COSMETIC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.88 THB | +1.24% |
|
+8.93% | +6.09% |
| Sales 2022 | 1.3B 35.27M 2.79B | Sales 2023 | 1.42B 38.47M 3.04B | Capitalization | 2.76B 74.91M 5.93B |
|---|---|---|---|---|---|
| Net income 2022 | 126M 3.42M 271M | Net income 2023 | 145M 3.94M 311M | EV / Sales 2022 * | - |
| Net Debt 2022 | 506M 13.74M 1.09B | Net cash position 2023 | 641M 17.4M 1.38B | EV / Sales 2023 | 1.5 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
17.2
x | Employees | 947 |
| Yield 2022 * |
-
| Yield 2023 |
2.17% | Free-Float | 27% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.24% | ||
| 1 week | +8.93% | ||
| Current month | -6.15% | ||
| 1 month | -8.79% | ||
| 3 months | -4.31% | ||
| 6 months | +3.39% | ||
| Current year | +6.09% |
1 week
4.48
4.90
1 month
4.365.50
Current year
4.365.75
1 year
4.006.85
3 years
4.0010.50
5 years
4.0010.50
10 years
4.0010.50
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/24 | 4.88 | +1.24% | 2,023,439 |
| 25/06/24 | 4.82 | +2.55% | 2,300,597 |
| 24/06/24 | 4.7 | +0.43% | 2,137,213 |
| 21/06/24 | 4.68 | +4.00% | 1,820,874 |
| 20/06/24 | 4.5 | +0.45% | 2,156,701 |
End-of-day quote Thailand S.E., June 25, 2024
More quotes
Bangkok Lab and Cosmetic Public Company Limited is a Thailand-based producer and researcher of health products. The principal activities of the Company and subsidiaries are engaged in the manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals. It operates through pharmaceuticals and medicinal chemical products segment. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, Calza-750 TAB FC, and others. Its subsidiaries include Bangkok Drug Co., Ltd., and Pharma Alliance Co., Ltd.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +6.09% | 79.28M | |
| +54.61% | 811B | |
| +43.33% | 640B | |
| -6.33% | 353B | |
| +20.62% | 333B | |
| +10.44% | 302B | |
| +17.96% | 246B | |
| +2.49% | 225B | |
| +12.62% | 218B | |
| +8.61% | 168B |
- Stock Market
- Equities
- BLC Stock
